[{"AccountsPayableCurrent_0_Q1_USD":39438000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q1_USD":4057000.0,"EarningsPerShareDiluted_1_Q1_USD":0.04,"SellingAndMarketingExpense_1_Q1_USD":3267000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":597000.0,"OtherNonoperatingIncome_1_Q1_USD":164000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":4057000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":520000.0,"DeferredIncomeTaxesAndTaxCredits_1_Q1_USD":116000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":4173000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":4057000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":81024000.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":1257000.0,"NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1_Q1_USD":12140000.0,"NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_1_Q1_USD":-194000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":231516000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":84537538.0,"OtherAssetsNoncurrent_0_Q1_USD":629000.0,"InterestIncomeExpenseNet_1_Q1_USD":150000.0,"NonoperatingIncomeExpense_1_Q1_USD":314000.0,"UnbilledReceivablesCurrent_0_Q1_USD":21100000.0,"TemporaryEquityLiquidationPreference_0_Q1_USD":0.0,"ValuationAllowancesAndReservesChargedToCostAndExpense_1_Q1_USD":1257000.0,"ValuationAllowancesAndReservesBalance_0_Q1_USD":8477000.0,"TreasuryStockCommonValue_0_Q1_USD":1009000.0,"TreasuryStockCommonShares_0_Q1_shares":615980.0,"TemporaryEquitySharesOutstanding_0_Q1_shares":0.0,"TemporaryEquitySharesIssued_0_Q1_shares":0.0,"TemporaryEquitySharesAuthorized_0_Q1_shares":100000000.0,"TemporaryEquityIssuePeriodIncreaseOrDecrease_1_Q1_USD":0.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q1_USD":0.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":791000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_1_Q1_USD":-693000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":3256000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":11252000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":91634000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2049000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":15127620.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2049000.0,"ValuationAllowancesAndReservesDeductions_1_Q1_USD":4000.0,"Goodwill_0_Q1_USD":11880000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":64422000.0,"LiabilitiesCurrent_0_Q1_USD":59056000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":180145000.0,"Liabilities_0_Q1_USD":59056000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-561000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":20054000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":20359000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":116000.0,"GrossProfit_1_Q1_USD":16602000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":9476000.0,"CommonStockValue_0_Q1_USD":8000.0,"CommonStockSharesOutstanding_0_Q1_shares":84845828.0,"CommonStockSharesIssued_0_Q1_shares":84845828.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":91634000.0,"AssetsCurrent_0_Q1_USD":161938000.0,"Assets_0_Q1_USD":180145000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":372420.0,"AccountsReceivableNetCurrent_0_Q1_USD":65862000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-194000.0,"EarningsPerShareBasic_1_Q1_USD":0.05,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-693000.0,"NetIncomeLoss_1_Q1_USD":4057000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":68000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":2025000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":8477000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":99665158.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":597000.0,"ShareBasedCompensation_1_Q1_USD":2049000.0,"OperatingIncomeLoss_1_Q1_USD":3859000.0,"OperatingExpenses_1_Q1_USD":12743000.0,"CommonStockSharesAuthorized_0_Q1_shares":1000000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"StockholdersEquity_0_Q1_USD":121089000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-109426000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":3673000.0,"ProfitLoss_1_Q1_USD":4057000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":4442000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":693000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":12140000.0,"EntityListingParValuePerShare_1_Q1_USD":0.0001,"Ticker":"PGNY","CIK":"1551306","name":"PROGYNY, INC.","OfficialName":"Progyny Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3963497917.0","Country":"United States","Sector":"Health Care","Industry":"Managed Health Care","Market":"NASDAQ","SP500":"nan","filed":"20200514"}]